Chronic Lung Diseases: Can Regenerative Medicine Offer New Hope?

Understanding Chronic Lung Diseases

Breathing is one of the necessities and feels effortless for all of us- until chronic lung disease takes away that ease silently. 

Chronic lung disease, or Chronic respiratory disease (CRD), affects the airways and other lung functions. The most common lung disease includes asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Globally, an estimate of 468.3 million individuals are living with CRDs, with 4.4 millions mortality cases [1]. The decline of respiratory function significantly increases the health burden. The current treatment regime is non-curative for CRDs, that is, they focus on symptom exacerbation. 

The increasing disease burden calls for effective measures that can address the disease’s root cause. In the last few decades, the boom in regenerative medicine has made breakthroughs in reversing Chronic Lung Diseases, including CRDs. Here, we explore the possibilities of regenerative medicine in enhancing lung support. 

Ask The Expert

Types of Lung Diseases Affecting Respiratory Health

Lung diseases are mainly sub-categorized as restrictive, obstructive and vascular diseases. These diseases affect the respiratory system differently. Understanding each subtype enables better choices in setting treatment goals. This includes:

• Restrictive Lung Disease: This condition is associated with inflammation, stiffness or scarred lung tissues. The appearance of the condition makes air inhalation difficult. E.g. Pulmonary fibrosis (idiopathic pulmonary fibrosis). Sarcoidosis, work-associated lung disease (black lung, silicosis, etc.)
• Obstructive Lung Disease: The airway gets blocked or obstructed. This makes it harder to breathe out the air from the lungs. The airway becomes inflamed, mucus builds up on the respiratory walls, and air sacs become damaged. E.g. COPD, Asthma, cystic fibrosis, bronchiectasis
• Pulmonary Vascular Disease: lung disease where blood vessels of the lungs are affected. Heart and lung function are compromised simultaneously, which makes oxygenation in the body tough. E.g. Pulmonary hypertension, pulmonary embolism

Among all the above types of lung disease, asthma, COPD, and pulmonary fibrosis cases are predominant. 

Lung Disease Symptoms: Early Warning Signs You Should Not Ignore

The common lung disease symptoms include:

• Persistent chronic cough (last several days to weeks)
• Shortness of breath
• Wheezing 
• Chest tightness or chronic chest pain
• Fatigue, reduced tolerance to exercise
• Cyanosis (bluish lips or fingernails, low oxygen level supply indication)

Causes and Risk Factors Behind Chronic Lung Diseases

Lung diseases causes and risk factors include:

• Environmental Exposure: Subsequent exposure to air pollutants, smoking, toxins
• Occupational/ Workplace Hazards: Long-term exposure to occupational hazards like silica, asbestos, cadmium, chemical fumes
• Genetic Predisposition: Rare genetic disorders cause alpha-1 antitrypsin deficiency in the body, which prevents the body from producing proteins required for desirable lung function, causing emphysema
• Lung Infection: Pathogen exposure (bacteria, fungi, viruses) triggers airway inflammation  

Current Treatment Regime for Chronic Lung Diseases

Conventional treatment regimens for Lung Diseases aim to address the symptoms. The current treatment includes:

Palliative/ Pharmacological Care

• Medications, anti-fibrotics like nintedanib, pirfenidone
• Inhalers, including bronchodilators or corticosteroids, that support breathing
• Antibiotics, to combat pulmonary infection

Non-Pharmacological Support

• Pulmonary rehabilitation, structured personalized exercise for physical endurance and improving breathing 
• Oxygen therapy supports hypoxemia and reduces comorbidity
• Lifestyle changes (smoking cessation)
• Nutritional Support, dietary intervention including intake of antioxidants (Vitamin C, D, and E)

*The above therapy aims in management of the disease symptoms rather than reversing pulmonary damage. 

Regenerative Medicine: A New Frontier in Lung Disease Management

In the past few decades, regenerative approaches, especially stem cell therapy, have emerged as curative solutions for chronic lung disease management. Regenerative technology sprints in its application in clinical trial forms. Scientists and clinicians believe stem cell treatment for lung diseases is a curative, next-gen solution. 

How Stem Cell Therapies Support Lung Repair?

In stem cell research, umbilical cord-derived mesenchymal stem cells (MSCs) have shown a boom in lung repair mechanisms. The cells differentiate into various body cells, including lung cells. MSCs are administered in a patient’s body to aid in damaged lung cell regeneration. Stem cells induce lung repair via multifold mechanisms. This includes:

• Regeneration of Lung Tissue: Stem cells differentiate into lung cells, restoring lung function  
• Tissue Repair: MSCs release various growth factors that promote tissue repair. The function of the surrounding tissue damaged area is restored, promoting appropriate lung function.
• Anti-Inflammation: MSCs release various anti-inflammatory cytokines that reduce respiratory tract inflammation
• Facilitating Cellular Communication: Stem cells promote cell-to-cell communication, facilitate signal exchange, promote tissue repair, homeostasis, and reduce inflammation. 

Scientific Research Supporting Regenerative Approaches

Preclinical and clinical trials support the effectiveness of stem cell therapy for restoring lung damage. The evidence includes:

• Administration of MSCs showed Improvement in lung function and a significant reduction in other IPF symptoms.
• In COPD patients, MSCs showed a significant reduction in inflammation and improved lung function [2]
• In ARDS patients, MSC therapy enabled a reduction in lung inflammation and promoted lung tissue regeneration and repair [3]
• In Cystic fibrosis, another chronic lung disease, MSCs displayed a positive outcome [4]

*All the above studies defined patient safety and tolerance. The success of the treatment depends on the source and quality of the stem cells. Advancells, India, is among the renowned stem cell research laboratories that source MSCs from umbilical cord tissue/blood. The cells isolated are of superior quality and undergo a stringent quality check process.  

Future Perspectives: Can Regenerative Medicine Transform Lung Disease Care?

The future of regenerative medicine in transforming chronic lung disease is promising. Stem cell therapy is still at an early stage. The future of the regenerative approach includes:

• Standardization of cell source isolation and dosage
• Large-scale clinical trial for determining long-term safety
• A combination of gene-editing technique (CRISPR-Cas9) with stem cell therapy
• Development of personalized approach for reversing lung damage

Conclusion 

Regenerative medicine holds new hope for patients with chronic lung diseases. These emerging therapies potentially enable lung regenerative and normal function restoration. With continued research, regenerative medicine can bring long-term positive outcomes and improved quality of life. 

References

1. Cao Z, He L, Luo Y, Tong X, Zhao J, Huang K, Chen Q, Jiao L, Liu Y, Geldsetzer P, Yang T. Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990–2021: results from the global burden of disease study 2021. Chinese Medical Journal Pulmonary and Critical Care Medicine. 2025 Jun 30;3(02):100-10.
2. Glassberg MK, Csete I, Simonet E, Elliot SJ. Stem cell therapy for COPD: hope and exploitation. Chest. 2021 Oct 1;160(4):1271-81.
3. Gazzaniga G, Voltini M, Carletti A, Lenta E, Meloni F, Briganti DF, Avanzini MA, Comoli P, Belliato M. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis. Respiratory Research. 2024 Apr 18;25(1):170.
4. Hayes Jr D, Kopp BT, Hill CL, Lallier SW, Schwartz CM, Tadesse M, Alsudayri A, Reynolds SD. Cell therapy for cystic fibrosis lung disease: regenerative basal cell amplification. Stem cells translational medicine. 2019 Mar 1;8(3):225-35.

FAQ’s

Q- What are Common Types of Chronic Lung Diseases?

Common Types of Lung Diseases: asthma, COPD, and pulmonary fibrosis. 

Q- What are the Early Lung Disease Symptoms? 

The common lung disease symptoms include persistent cough, breathlessness, wheezing, chest tightness, fatigue, etc. The early diagnosis can potentially result in better outcomes.

Q- What is Pulmonary Fibrosis Treatment?

Pulmonary fibrosis treatments include antifibrotic medication, inhalers, oxygen therapy, and pulmonary rehabilitation. In severe cases, lung transplantation is recommended. 

Q- Can Regenerative Medicine Cure CRDs?

Currently, preclinical and clinical trials have shown positive outcomes and tolerability among patients with CRDs. in future research must consider large-scale clinical trials to ensure long-term safety.